Cargando…
Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease
Fibroblast growth factor 23 (FGF23) is a phosphaturic hormone that in end-stage renal disease is markedly increased in serum; however, the mechanisms responsible for this increase are unclear. Here, we tested whether phosphate retention in chronic kidney disease (CKD) is responsible for the elevatio...
Autores principales: | Zhang, Shiqin, Gillihan, Ryan, He, Nan, Fields, Timothy, Liu, Shiguang, Green, Troy, Stubbs, Jason R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758787/ https://www.ncbi.nlm.nih.gov/pubmed/23698235 http://dx.doi.org/10.1038/ki.2013.194 |
Ejemplares similares
-
Multiple Looser zones of osteomalacia in Byler disease with associated vitamin D deficiency, phosphaturia, and elevated FGF23
por: Tarazi, M., et al.
Publicado: (2015) -
Sirolimus Induced Phosphaturia is Not Caused by Inhibition of Renal Apical Sodium Phosphate Cotransporters
por: Haller, Maria, et al.
Publicado: (2012) -
Phosphate and FGF-23
por: Jüppner, Harald
Publicado: (2011) -
FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2–SGK1 signaling pathway
por: Andrukhova, Olena, et al.
Publicado: (2012) -
A Case of Alternating Oxaluria and Phosphaturia
por: Brasher, C. W. J.
Publicado: (1913)